Publication & Citation Trends
Publications
0 total
Discovery of an ITK and TRK kinase inhibitor for the potential topical treatment of atopic dermatitis.
Cited by 1
Semantic Scholar
Phosphodiesterase-4 inhibitors increase pigment cells proliferation and melanization in cultured melanocytes and within a 3D skin equivalent model.
Cited by 6
Semantic Scholar
Discovery and multi-parametric optimization of a high-affinity antibody against interleukin-25 with neutralizing activity in a mouse model of skin inflammation OA
Cited by 6
Semantic Scholar
IL-13 Controls IL-33 Activity through Modulation of ST2 OA
Cited by 15
Semantic Scholar
722 Type 2 helper T-cell (Th2) effects of crisaborole versus 3 topical corticosteroids (TCSs) with a range of potencies: An ex vivo human skin model study OA
Cited by 0
Semantic Scholar
Anti-ll-33, compositions, methods and uses thereof
Cited by 0
Semantic Scholar
Alternative splicing of interleukin-33 and type 2 inflammation in asthma OA
Cited by 146
Semantic Scholar
IL1RL1 asthma risk variants regulate airway type 2 inflammation. OA
Cited by 53
Semantic Scholar
Research Topics
Asthma and respiratory diseases
(14)
Mast cells and histamine
(13)
Chronic Obstructive Pulmonary Disease (COPD) Research
(7)
IL-33, ST2, and ILC Pathways
(7)
Receptor Mechanisms and Signaling
(5)
Affiliations
Tulane University
Merck & Co., Inc., Rahway, NJ, USA (United States)
Pfizer (United States)
Pfizer (United Kingdom)
Cornell University